Frost & Sullivan

MAY 7, 2023

May 8, 2023 – Frost & Sullivan today announced that it has awarded Genomenon with the 2023 Global Technology Innovation Leadership Award. Genomenon empowers rare disease pharmaceutical and biotechnology companies to make informed decisions about promising candidates in their pipeline and help propel novel therapeutics to market.

Biotechnology 52

Biotechnology Engineering Life science 52

Frost & Sullivan

JUNE 21, 2022

The merger, which is expected to be completed by 2023, will form a new entity called DSM-Firmenich that will be segmented into four strategic business units : Perfumery & Beauty. Animal Nutrition & Health. Health, Nutrition & Care. The two companies balance each other in terms of their expertise across the botanicals space.

Biotechnology 52

Biotechnology Engineering 52

Frost & Sullivan

JUNE 21, 2022

The merger, which is expected to be completed by 2023, will form a new entity called DSM-Firmenich that will be segmented into four strategic business units : Perfumery & Beauty. Animal Nutrition & Health. Health, Nutrition & Care. The two companies balance each other in terms of their expertise across the botanicals space.

Biotechnology 52

Biotechnology Engineering 52

Frost & Sullivan

JANUARY 17, 2023

17, 2023– The agricultural industry’s ongoing changes—rapid climate change and biodiversity loss—have created a lucrative growth opportunity for agrochemical technology developers. San Antonio – Jan.

Biotechnology 52

Biotechnology Strategic partnership Government Collaboration 52

Frost & Sullivan

APRIL 25, 2023

April 25, 2023 – Frost & Sullivan researched the contract research organizations industry and, based on its analysis results, recognizes Emmes with the 2023 Global Competitive Strategy Leadership Award. federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

LaVoie Health Science Blog

JUNE 14, 2023

The Biotechnology Industry Organization understands this need and has been leading in this area for more than a decade now. Here is a summary of our recommendations from BIO International 2023 ; you also may want to check out this video on corporate presentation best practices.

Biotechnology 52

Biotechnology Life science Legal 52

LaVoie Health Science Blog

JANUARY 30, 2023

Smaller Biotechs Need to Pivot : The valuation of smaller biotechnology companies is down considerably compared to previous years, but that does not mean it is time to panic, it means it is time to pivot. The post Biotech is Back to Work: JPM 2023 Week Wrap Up appeared first on LaVoie Health Science.

Biotech 98

Biotech Biotechnology Finance Data partnerships 98

Frost & Sullivan

MARCH 28, 2025

The pharmaceutical and biotechnology industries are at the cusp of a transformative era in 2025, driven by cutting-edge innovation, evolving regulations, and increasing market pressures. Between 2017 and 2023, the US RLT market saw over 550% growth in total venture capital deals. The market for RLT is set for exponential growth.

Biotech 52

Biotech Biotechnology Strategic partnership Insurance 52

Frost & Sullivan

MARCH 28, 2025

Elabscience Biotechnology, Inc., Quanterix, Response Biomedical Corp., Tosoh Bioscience, Tulip Diagnostics Pvt. Notable Mergers & Acquisitions Roches acquisition of LumiraDxs POC business will enhance its POC capabilities and market presence.

Biotechnology 52

Biotechnology Biotech Ecosystems 52

Frost & Sullivan

JANUARY 23, 2025

While 2024 saw a 41% decline in aggregate deal value , falling from $222 billion in 2023 to $130 billion, 2025 is poised for a rebound. The post JP Morgan Healthcare Conference 2025: Key Growth Opportunities Shaping the Future of Pharma and Biotechnology appeared first on Frost & Sullivan.

Biotechnology 52

Biotechnology Mergers and acquisition activities Biotech Biopharma 52